Hey Iroko HELP

Quote

anonymous

Guest
Please, Let's talk about the elephants in the room...managed care and pharmacies. Would you PLEASE consider some type of deal with a specialty pharmacy? It sounds like American Specialty Pharmacy may be a potential answer, except they are in bed with Horizon (Ya know, Vimovo/Duexis/Pennsaid). Call them please and work out a deal: 214-919-2520. I KNOW Expert Encounter Links NOR speaker programs or whatever with paying docs are NOT making an impact. My speaker said he was done, but would keep writing for ME. This ASP (pharmacy) is located in Plano, Texas and business is growing around this area? Wake up Andrew B, PLEASE. OR get coverage and care. Oh, and btw Chris M has screwed the sales team with targeting because many big writers did not even show up on his fancy radar. He is worthless. Your reps are seeing the issues. Please face them. Get a managed care team and stop wasting money. You are positioning us and you to lose. Btw, muscle man MD is leading the SE down the wrong track. How does he go from the bottom as an RBM and then become a AVP??? SO not fair! WAkE UP!!
 




Pure ignorance in the posting. Zorvolex has great managed care coverage in non-medicare and non-medicaid plans in most areas. Download the MMIT app and you can see for yourself the coverage by the number of lives in your area. In most areas in the US, the top payors for commercial lives are Express Scripts, CVS Caremark, Anthem Wellpoint, Aetna, the local BCBS plan and United. Except for United, most plans have Zorvolex in 2Tier or 3rd Tier position for most of their commercial lives with some plans having a single step. Important to understand that while these payors cover Zorvolex in 2T or 3T for most of their commercial lives, they also offer some restricted benefit designs to their cost conscious customers - where there may be access for generics in return for lower monthly premiums. If you have a good idea of what % of commercial lives in your territory is covered by what payor and the breakdown of benefit designs by payor and look at the objective evidence of coverage (rather than anecdotal evidence or isolated incidence), you will realize that most of the territories have great managed care access for commercial lives. You have to also realize that when the physician says that he got a claim rejected, if you do the diagnosis on that most times the claim may be for a medicare patient, health exchange patient or someone with a restricted benefit design. If you had knowledge of the proportion of the commercial lives for that payor by that restricted benefit design in your area, you will be able to reassure your physician with that context. Sometimes physicians say this just to put you on the defensive to stop you from nagging them.

You have to realize that there is no magic bullet where every single plan and payor is going to cover a pharma product today be it Sovaldi or the new heart failure drug from Novartis or any other branded product. That is the reality of today's managed care landscape for all of pharma. With the different plans under a payor and the various benefit designs, it is a maze. If you really want to be successful selling at Iroko or any other branded pharma company today, you need to understand the details of this complex managed care landscape in your territory so that you can provide the context to the physician. Success will depend on navigating to the coverage you have rather than worry about the payors who do not cover you. There are enough prescriptions in each territory where you have coverage to be taken.
 






anonymous said:
Pure ignorance in the posting. Zorvolex has great managed care coverage in non-medicare and non-medicaid plans in most areas. Download the MMIT app and you can see for yourself the coverage by the number of lives in your area. In most areas in the US, the top payors for commercial lives are Express Scripts, CVS Caremark, Anthem Wellpoint, Aetna, the local BCBS plan and United. Except for United, most plans have Zorvolex in 2Tier or 3rd Tier position for most of their commercial lives with some plans having a single step. Important to understand that while these payors cover Zorvolex in 2T or 3T for most of their commercial lives, they also offer some restricted benefit designs to their cost conscious customers - where there may be access for generics in return for lower monthly premiums. If you have a good idea of what % of commercial lives in your territory is covered by what payor and the breakdown of benefit designs by payor and look at the objective evidence of coverage (rather than anecdotal evidence or isolated incidence), you will realize that most of the territories have great managed care access for commercial lives. You have to also realize that when the physician says that he got a claim rejected, if you do the diagnosis on that most times the claim may be for a medicare patient, health exchange patient or someone with a restricted benefit design. If you had knowledge of the proportion of the commercial lives for that payor by that restricted benefit design in your area, you will be able to reassure your physician with that context. Sometimes physicians say this just to put you on the defensive to stop you from nagging them.

You have to realize that there is no magic bullet where every single plan and payor is going to cover a pharma product today be it Sovaldi or the new heart failure drug from Novartis or any other branded product. That is the reality of today's managed care landscape for all of pharma. With the different plans under a payor and the various benefit designs, it is a maze. If you really want to be successful selling at Iroko or any other branded pharma company today, you need to understand the details of this complex managed care landscape in your territory so that you can provide the context to the physician. Success will depend on navigating to the coverage you have rather than worry about the payors who do not cover you. There are enough prescriptions in each territory where you have coverage to be taken.
Click to expand...
 


Keep on drinking the Kool Aid. You must be an RBM who is lied to, an AVP who is cocky with no clue, or a narcissistic VP. MMIT is what confirmed to this company that a PA and double step edit was slapped on Z on our largest plan in our state. No, I am not being lied to in my offices who see no Medicaid and very little Medicare. I hear the dictations, I see the prescriptions and I see the PAs. We need to remove the obstacles: pharmacies and be be able to streamline PAs. Let's do what all the other companies are doing. Don't ask why we are flat and not growing if you cannot do this. I am fortunate to not be declining. Iroko will fail and I am just trying to give a solution.
 


its for you decipher....if you want put more faith in episodic observations that you make in physician offices, not knowing the patient particulars - what is their medical benefit, how their pharmacy benefit is paid, the benefit designs etc - and make generalizations. What I had written about is actual data on lives distribution by payer by their different plans, the actual composition of those players by territory and formularies that are verified by two independent syndicated data providers. In addition, data by IMS and Symphony also provide factual information on claims that are paid and rejected. What I quote is objective, real data. Many a times, people make mistake of taking a few episodes they witness and make broad generalizations. Only awareness of that and gathering the objective knowledge could help you. Its up to you to living in your fallacy and blame everything else or try to learn, gather objective knowledge and succeed. I can only show you the water but cant make you drink it.
 


anonymous said:
Former rep here, serious question. What happened to the Linden Care specialty pharmacy? My former RBM kept promoting that as the answer.
Click to expand...

Total shite. They weren't holding up their end. Not doing the PAs, lettung stuff linger. ASP is on board. Best kept secret in Texas. They won't sell you out to Horizon even though Horizon is giving away anything that's not approved for free. Alot of my hcps think horizons offerings are crap so you need not worry about the conflict if you send the biz there. Your drs won't sign the pas if they don't like them. Managed care and the big box pharmacies are our biggest obstacles.
 


anonymous said:
Pure ignorance in the posting. Zorvolex has great managed care coverage in non-medicare and non-medicaid plans in most areas. Download the MMIT app and you can see for yourself the coverage by the number of lives in your area. In most areas in the US, the top payors for commercial lives are Express Scripts, CVS Caremark, Anthem Wellpoint, Aetna, the local BCBS plan and United. Except for United, most plans have Zorvolex in 2Tier or 3rd Tier position for most of their commercial lives with some plans having a single step. Important to understand that while these payors cover Zorvolex in 2T or 3T for most of their commercial lives, they also offer some restricted benefit designs to their cost conscious customers - where there may be access for generics in return for lower monthly premiums. If you have a good idea of what % of commercial lives in your territory is covered by what payor and the breakdown of benefit designs by payor and look at the objective evidence of coverage (rather than anecdotal evidence or isolated incidence), you will realize that most of the territories have great managed care access for commercial lives. You have to also realize that when the physician says that he got a claim rejected, if you do the diagnosis on that most times the claim may be for a medicare patient, health exchange patient or someone with a restricted benefit design. If you had knowledge of the proportion of the commercial lives for that payor by that restricted benefit design in your area, you will be able to reassure your physician with that context. Sometimes physicians say this just to put you on the defensive to stop you from nagging them.

You have to realize that there is no magic bullet where every single plan and payor is going to cover a pharma product today be it Sovaldi or the new heart failure drug from Novartis or any other branded product. That is the reality of today's managed care landscape for all of pharma. With the different plans under a payor and the various benefit designs, it is a maze. If you really want to be successful selling at Iroko or any other branded pharma company today, you need to understand the details of this complex managed care landscape in your territory so that you can provide the context to the physician. Success will depend on navigating to the coverage you have rather than worry about the payors who do not cover you. There are enough prescriptions in each territory where you have coverage to be taken.
Click to expand...

I'll try not to be too cynical, but if you don't cover a territory with an affluent population, coverage is pretty crappy. Do you really think I can get a dr to do M&M after every rejected script? Iroko does not offer drugs that show a clear improvement over existing meds like new groundbreaking drugs. We just aren't paid enough to dig and investigate every failed script. Then what happens when your research doesn't yield the potential for a positive outcome, like rphs diverting rxes and carve outs that really do reject your drugs despite the mc info in Veeva. Most plans have more flavors than the new coke dispenser at Wendy's. In the end, Iroko is going to choke on its own frugality. Start by dumping Javelin and then respect the reps input about who is gone and who is seeing pts in their area.
 






anonymous said:
Good grief! Get over yourself, you're a rent a rep! Iroko gives not one shit what you think!
Click to expand...

Any company that does not listen to its employees, let alone its ears on the street, is doomed to failure. I think most of us recognize our positions here but if Iroko chooses to ignore our insights its their own fault. They want us to sell our selves as "consultants" to the hcps?!? Then accept the feedback we bring in. And stop being a holier than thou a-hole. 99.99999% are pawns in this world.
 




i agree. The promised land of unemployment, gates of Hell, lies, deceit and an endless path of destruction. Just what is needed for a career. Thank God I'm gone and c'mon fellow reps, there are jobs out there that will hire you instantly
 


anonymous said:
Any company that does not listen to its employees, let alone its ears on the street, is doomed to failure. I think most of us recognize our positions here but if Iroko chooses to ignore our insights its their own fault. They want us to sell our selves as "consultants" to the hcps?!? Then accept the feedback we bring in. And stop being a holier than thou a-hole. 99.99999% are pawns in this world.
Click to expand...
 




anonymous said:
I'll try not to be too cynical, but if you don't cover a territory with an affluent population, coverage is pretty crappy. Do you really think I can get a dr to do M&M after every rejected script? Iroko does not offer drugs that show a clear improvement over existing meds like new groundbreaking drugs. We just aren't paid enough to dig and investigate every failed script. Then what happens when your research doesn't yield the potential for a positive outcome, like rphs diverting rxes and carve outs that really do reject your drugs despite the mc info in Veeva. Most plans have more flavors than the new coke dispenser at Wendy's. In the end, Iroko is going to choke on its own frugality. Start by dumping Javelin and then respect the reps input about who is gone and who is seeing pts in their area.
Click to expand...
 







Write your reply...
Top Bottom
Back
Quote